Lohman Technologies Funding: How Much Did They Raise & Key Investors

How Much Did Lohman Technologies Raise?
Funding & Key Investors

Lohman Technologies has successfully secured a significant capital injection, marking a pivotal moment in its trajectory as it scales its cardiac monitoring solutions. With a total cumulative investment reaching $20K, the firm is well-positioned to accelerate its market penetration. This latest financing round, which contributed $20K in substantial expansion capital, underscores investor confidence in the company's proprietary diagnostic hardware and its ability to address the growing demand for remote heart rhythm management.

The infusion of funds arrives at a critical juncture for the Sussex-based innovator, enabling the company to transition from its established roots in Holter scanning services toward a broader, more integrated ecosystem of mobile cardiac diagnostics. By leveraging this recent backing, Lohman Technologies aims to solidify its footprint in the competitive landscape of arrhythmia detection and patient-centric healthcare technology.

What is Lohman Technologies?

Lohman Technologies

Manufacturing

Medical Devices & Equipment

Healthcare Services

Founded in 2004 by the Lohman family, Lohman Technologies operates at the intersection of medical device engineering and clinical cardiology. The company specializes in the development of advanced, mobile-first cardiac monitoring systems, including its patented Genesis ECG Memory Loop Recorder and the AfibAlert platform. These technologies are designed to provide high-fidelity, real-time data to physicians, facilitating the accurate diagnosis and long-term management of atrial fibrillation and other transient heart arrhythmias. By prioritizing ease of use and clinical accuracy, the firm has carved out a distinct niche, offering a lifetime solution for patients managing chronic cardiac conditions while simultaneously reducing the burden on emergency healthcare infrastructure.

How much funding has Lohman Technologies raised?

Lohman Technologies has raised a total of $20K across 1 funding round:

2021

Debt

$20K

Debt (2021): $20K with participation from PPP

Key Investors in Lohman Technologies

PPP

Public-Private Partnership

What's next for Lohman Technologies?

With the recent influx of capital, Lohman Technologies is poised to scale its operational capacity and expand its reach within the clinical research and outpatient monitoring sectors. The strategic roadmap likely involves enhancing the algorithmic capabilities of its AfibAlert system and potentially diversifying its patent portfolio to include next-generation power management solutions, such as its polarity-correcting DC-to-DC converter technology. As the healthcare industry continues to shift toward decentralized, remote patient monitoring, Lohman Technologies is strategically positioned to capitalize on the increasing necessity for high-quality, patient-friendly diagnostic tools. Future growth will likely focus on deepening physician adoption and integrating its data streams into broader electronic health record systems to improve clinical outcomes.

See full Lohman Technologies company page

See More Financial Insights